Impact of ATP synthase/coupling factor 6 in hypoxic pulmonary arterial hypertension: An experimental rat model

BACKGROUND/AIM: Hypoxia-induced pulmonary arterial hypertension (PAH) is characterized by prostacyclin (PGI(2)) disorder, which manifests in the same manner as in monocrotaline (MCT)-induced PAH. Endogenous PGI(2) inhibitor coupling factor 6 (CF6) is involved in MCT-induced PAH. This study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: LI, Nannan, SHI, Yugen, YIN, Jie, SUN, Li, ZHANG, Qingshan, BAO, Shuai, ZHANG, Juan, LI, Youlei, WANG, Miaomiao, ZHANG, Yanwei, XUE, Mei, QI, Lei, LI, Yan, YAN, Suhua, LI, Xiaolu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific and Technological Research Council of Turkey (TUBITAK) 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395693/
https://www.ncbi.nlm.nih.gov/pubmed/36422496
http://dx.doi.org/10.55730/1300-0144.5485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395693/
https://www.ncbi.nlm.nih.gov/pubmed/36422496
http://dx.doi.org/10.55730/1300-0144.5485

Ejemplares similares